Lv1
10 积分 2025-12-28 加入
Current status and new treatment approaches in TP53 mutated AML
1小时前
待确认
Long term results of venetoclax combined with FLAG-IDA induction and consolidation for newly diagnosed and relapsed or refractory acute myeloid leukemia
7小时前
已完结
Long term results of venetoclax combined with FLAG-IDA induction and consolidation for newly diagnosed and relapsed or refractory acute myeloid leukemia
29天前
已完结
Philadelphia-chromosome positive acute lymphoblastic leukemia: ten frequently asked questions
1个月前
已完结
The Genomic Landscape and Its Clinical Implication in NPM1-Mutated AML Patients: A Study within the AMLSG 09-09 Clinical Trial
4个月前
已完结
Reduced dose azacitidine plus venetoclax as maintenance therapy in acute myeloid leukaemia following intensive or low-intensity induction: a single-centre, single-arm, phase 2 trial
5个月前
已完结
皖公网安备34019202002308
